Home › Trial NCT07333469
A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma
- Trial IDNCT07333469
- StatusNot Yet Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorHanx Biopharmaceuticals (Wuhan) Co., Ltd.
- Enrollment70
- Start date2026-01-19
- ConditionsSolid Tumor and Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.